SEC ownership of Pharming Group N.V.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001828316.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

12/12

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
12 of 12
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
MORGAN STANLEY
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001828316
Issuer location
Leiden, Netherlands

Ownership snapshot

Top shareholders of Pharming Group N.V. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
12/12
Latest evidence
31 Mar 2026
13D/G 13F Lead comparable stake: 1.2% 13D/G row: MORGAN STANLEY Showing 1-8 of 12 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 1.2%.

12 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 5
MORGAN STANLEY 1.2%
Silverberg Bernstein Capital Mana... 0.01%
SmartHarvest Portfolios, LLC 0%
CITADEL ADVISORS LLC 0%
Knoll Capital Management, LLC 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 12 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13D/G 13F
Company
1.2%
$70,739,538
8,471,801 shares
$0 31 Mar 2025
Silverberg Bernstein Capital Management LLC
13F
Company
13F
0.01%
$744,590
44,747 shares
31 Mar 2026
SmartHarvest Portfolios, LLC
13F
Company
13F
0%
$179,662
10,797 shares
31 Mar 2026
CITADEL ADVISORS LLC
13F
Company
13F
0%
$169,545
10,189 shares
31 Mar 2026
Knoll Capital Management, LLC
13F
Company
13F
0%
$67,508
4,057 shares
31 Mar 2026
NewEdge Advisors, LLC
13F
Company
13F
0%
$35,777
2,150 shares
31 Mar 2026
EverSource Wealth Advisors, LLC
13F
Company
13F
0%
$9,268
557 shares
31 Mar 2026
BNP PARIBAS FINANCIAL MARKETS
13F
Company
13F
0%
$6,656
400 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 07 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Pharming Group N.V.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .